Skin microvascular dysfunction as an early cardiovascular marker in primary hyperoxaluria type I-Reference-Cited by-同舟云学术

Skin microvascular dysfunction as an early cardiovascular marker in primary hyperoxaluria type I

Published:2018-10-01 Issue:2 Volume:34 Page:319-327
ISSN:0931-041X
Container-title:Pediatric Nephrology
language:en
Short-container-title:Pediatr Nephrol

Author:

Bruel Alexandra,Bacchetta Justine,Ginhoux Tiphanie,Rodier-Bonifas Christelle,Sellier-Leclerc Anne-Laure,Fromy Bérengère,Cochat Pierre,Sigaudo-Roussel Dominique,Dubourg Laurence

Publisher

Springer Science and Business Media LLC

Subject

Nephrology,Pediatrics, Perinatology and Child Health

Link

http://link.springer.com/article/10.1007/s00467-018-4081-5/fulltext.html

Reference44 articles.

1. Harambat J, van Stralen KJ, Espinosa L, Groothoff JW, Hulton S-A, Cerkauskiene R, Schaefer F, Verrina E, Jager KJ, Cochat P, European Society for Pediatric Nephrology/European Renal Association-European Dialysis and Transplant Association (ESPN/ERA-EDTA) Registry (2012) Characteristics and outcomes of children with primary oxalosis requiring renal replacement therapy. Clin J Am Soc Nephrol 7:458–465

2. Beck BB, Hoyer-Kuhn H, Göbel H, Habbig S, Hoppe B (2013) Hyperoxaluria and systemic oxalosis: an update on current therapy and future directions. Expert Opin Investig Drugs 22:117–129

3. Cochat P, Hulton S-A, Acquaviva C, Danpure CJ, Daudon M, De Marchi M, Fargue S, Groothoff J, Harambat J, Hoppe B, Jamieson NV, Kemper MJ, Mandrile G, Marangella M, Picca S, Rumsby G, Salido E, Straub M, van Woerden CS, OxalEurope (2012) Primary hyperoxaluria type 1: indications for screening and guidance for diagnosis and treatment. Nephrol Dial Transplant 27:1729–1736

4. Fargue S, Milliner DS, Knight J, Olson JB, Lowther WT, Holmes RP (2018) Hydroxyproline metabolism and oxalate synthesis in primary hyperoxaluria. J Am Soc Nephrol 29:1615–1623

5. Zhao F, Bergstralh EJ, Mehta RA, Vaughan LE, Olson JB, Seide BM, Meek AM, Cogal AG, Lieske JC, Milliner DS, Investigators of Rare Kidney Stone Consortium (2016) Predictors of incident ESRD among patients with primary hyperoxaluria presenting prior to kidney failure. Clin J Am Soc Nephrol 11:119–126

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of the microcirculation state in children with acute bronchitis;CHILD`S HEALTH;2023-12-07

2. Skin Cell and Tissue Responses to Cross-Linked Hyaluronic Acid in Low-Grade Inflammatory Conditions;International Journal of Inflammation;2023-08-26

3. ePHex: a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria;Pediatric Nephrology;2022-05-12

4. Effects of Oxalobacter formigenes in subjects with primary hyperoxaluria Type 1 and end-stage renal disease: a Phase II study;Nephrology Dialysis Transplantation;2020-08-18